NASDAQ : OGI

Organigram Global Inc.

$0.9521 USD

-$0.04 (-4.1%)

Volume
131.58K
Average Volume
563.83K
Market Capitalization
$134.03M
P/E Ratio
-7.23
Dividend Yield
0.00%
Price Target
Year High
$2.24
Year Low
$0.85
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.82
Company Overview

NASDAQ

James H. Yamanaka

Drug Manufacturers - Specialty & Generic

Healthcare

OGI

1120

CA

USD

https://www.organigram.ca

15063841571

68617J100

0001620737

Liquidity Metrics

0.02

2.82

1.30

0.61

0.00

Sales & Valuation

$186.09M

0.66

0.47

-8.99

-0.15

Profitability

-$0.14

-$17.78M

-9.19%

-14.18%

-6.83%

-4.84%

P/E Metrics

-7.23

-0.01

-0.01

Analyst Price Target & Rating

Neutral

3/5

5 Analysts

%

Financial Health Scores

-0.03

2/9

$161.76M

$522.66M

$149.89M

-$14.12M

Key Metrics (TTM)

$141.22M

0.52

-3.46

2.82

-6.83%

-15.84%

-13.99%

-10.80%

151 days

Company Executives
Name Title
Helen Martin Chief Legal Officer & Corporate Secretary
Nathalie Batten Senior Vice President of Operations
Valerie Rother Chief People Officer
Max Schwartz Director of Investor Relations
Greg Guyatt Chief Financial Officer
James H. Yamanaka Chief Executive Officer & Director
Paolo De Luca Chief Strategy Officer
Peter L. Amirault Executive Chairman
Timothy Emberg President of Organigram Canada
Bradley Gunter Senior Vice President of Sales
Poll Results

No votes yet today — be the first to share your view!

About Organigram Global Inc. (NASDAQ:OGI) Stock

Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis deriva ... tives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.

Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026

2026-08-04 06:00:00

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity”), announced today it will report earnings results for its third quarter ended June 30, 2026, on Tuesday, August 11, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, Aug.

Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share

2026-07-20 06:00:00

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity”), today provided a business update highlighting initial operating performance from Sanity, continued strength in its Canadian business, and upcoming investor engagement. "The first quarter following the acquisition of Sanity marks an important milest.

Organigram: Record Harvests Are The Root Of Market Share Erosion

2026-05-20 07:07:37

Organigram's disappointing Q2 earnings could be a direct result of its record harvests overwhelming downstream capacity. Expected Sanity contribution to full-year revenue and adjusted EBITDA guidance suggests that organic growth may turn negative in the second half of FY 2026. Persistent out-of-spec exports point to a severe bottleneck in drying capacity, where overcrowded drying rooms are fostering microbial growth and driving inconsistent drying.

Organigram Global Inc. (OGI:CA) Q2 2026 Earnings Call Transcript

2026-05-12 15:20:44

Organigram Global Inc. (OGI:CA) Q2 2026 Earnings Call Transcript

Organigram Says Vape Weakness Pressures Margins

2026-05-12 14:30:36

Organigram Global Inc. (NASDAQ:OGI) reported weaker second-quarter fiscal 2026 results as declining vape and infused pre-roll sales weighed on revenue and profitability.

OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates

2026-05-12 10:15:28

OrganiGram (OGI) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.05 per share a year ago.

Organigram Global Q2 Earnings Call Highlights

2026-05-12 09:07:50

Organigram Global NASDAQ: OGI reported a weaker second quarter for fiscal 2026, with management attributing the decline to operational issues in key product categories, softer Canadian cannabis market growth and continued challenges with international flower specifications.

Organigram Reports Second Quarter Fiscal 2026 Results

2026-05-12 06:00:00

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the second quarter ended March 31, 2026 (“Q2 Fiscal 2026” or "Q2"). Q2 FISCAL 2026 HIGHLIGHTS Gross Revenue: $93.3 million (-9% year-over-year). Net Revenue: $59.8 million (-9% year-over-year). International Revenue: $6.1 million (0% year-over-year). Adjusted EBITDA2: $0.9 million (-82% year-over-year).

Frequently Asked Questions

What is the current Organigram Global Inc. (OGI) stock price?

Organigram Global Inc.(NASDAQ:OGI) stock price is $0.9521 in the last trading session. During the trading session, OGI stock reached the peak price of $2.24 while $0.853 was the lowest point it dropped to. The percentage change in OGI stock occurred in the recent session was --4.1% while the dollar amount for the price change in OGI stock was -$0.04.

OGI's industry and sector of operation?

The NASDAQ listed OGI is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of OGI?

Helen Martin | Chief Legal Officer & Corporate Secretary
Nathalie Batten | Senior Vice President of Operations
Valerie Rother | Chief People Officer
Max Schwartz | Director of Investor Relations
Greg Guyatt | Chief Financial Officer

How many employees does OGI have?

Number of OGI employees currently stands at 1120. OGI operates from 145 King Street West, Toronto, ON M5H 1J8, CA.

Link for OGI official website?

Official Website of OGI is: https://www.organigram.ca

How do I contact OGI?

OGI could be contacted at phone #15063841571 and can also be accessed through its website. OGI operates from 145 King Street West, Toronto, ON M5H 1J8, CA.

How many shares of OGI are traded daily?

The average number of OGI shares traded daily for last 3 months was 563.83K.

What is the market cap of OGI currently?

The market value of OGI currently stands at $134.03M with its latest stock price at $0.9521